M&A Deal Summary |
|
|---|---|
| Date | 2009-12-21 |
| Target | Kaopectate |
| Sector | Consumer Products |
| Buyer(s) | Sanofi |
| Deal Type | Going Private |
| Deal Value | 1.9B USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Life Science |
| Employees | 82,878 |
| Revenue | 44.3B EUR (2024) |
Sanofi is a French multinational pharmaceutical company. Sanofi was founded in 1994 and is based in Paris, France.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 31 |
| Sector: Consumer Products M&A | 3 of 3 |
| Type: Going Private M&A Deals | 1 of 2 |
| State: Tennessee M&A | 1 of 1 |
| Country: United States M&A | 3 of 19 |
| Year: 2009 M&A | 8 of 8 |
| Size (of disclosed) | 7 of 15 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-10-30 |
Laboratoire Oenobiol S.A.S.
Paris, France Laboratoire Oenobiol S.A.S. produces, and supplies nutritional, health and beauty supplements. Oenobiol Solaire a nutritional supplement that protects the skin and favours a better suntan by activating melanin synthesis. Oenobiol supplements are scientifically approved products and are manufactured according to pharmaceutical standards. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-02-03 |
Medley Global Advisors
New York, New York, United States Medley Global Advisors is the provider of geopolitical and macroeconomic policy information serving a client base comprised of leading banks, asset managers, and hedge funds. |
Buy | €500M |